Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams

- Non-tobacco-using female subjects, 18 to 50 years of age

- Demonstrated blanching response to Reference Drug (augmented betamethasone dipropionate) Cream 0.05%

- Weight within + or - 20% from normal for height and weight for body frame

- Good health as determined by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator

- Signed and dated informed consent form which meets all criteria of current FDA regulations

- History of allergy to systemic or topical corticosteroids

- Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching

- Presence of medical condition requiring regular treatment with prescription drugs

- Drug or alcohol addiction requiring treatment in the past 12 months prior to dosing

- Use of any dermatological drug therapy on the flexor surface of the forearms within 30 days of dosing

- Use of any tobacco products in the 30 days prior to study dosing

- Receipt of any drugs as part of a research study within 30 days prior to study dosing

- Pregnant or lactating